Fingerprint
Dive into the research topics of 'A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: An NRG oncology RTOG group study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically